The Central Oregon Pain Standards Task Force formally adopted the Oregon Health Authority’s acute pain guidelines in March, and an upcoming meeting with area providers and surgeons will discuss how ...

The current retrospective chart review found a significant difference in pain management between non-Hispanic/Latino White patients and racial/ethnic minority patients and women. Non-Hispanic/Latino ...

CHICAGO, Feb. 5, 2024 – Nonsteroidal anti-inflammatory drugs (NSAIDs) taken alone or along with acetaminophen are recommended as first-line treatments for managing short-term dental pain in adults and ...

Biopsychosocial self-management was associated with significant but small reductions in disability in patients with acute low back pain.

ORLANDO, Fla. — Recurrent pain episodes are the leading reason for emergency department (ED) visits among patients with sickle cell disease, but adherence to established acute pain management ...

BOSTON--(BUSINESS WIRE)--More than 63,000 people in the US died of drug overdoses in 2016, and two-thirds of those overdoses involved prescription or illicit opioids. Even as health care providers ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Approximately 7.6 million individuals in the United States suffer from opioid use disorder (OUD). Three evidence-based medications—methadone, buprenorphine, and naltrexone—are recommended for use by ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of $82.28 million and impressive revenue growth of 22% over the last twelve ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...